NWPF

News ArchivesRead News

Parkinson's event at Buck draws hundreds

Thursday September 17, 2009

Jim Welte

Contra Costa Times - Researchers told more than 250 people packed into an auditorium at the Buck Institute for Age Research on Thursday that diagnosing and treating Parkinson's disease before people display symptoms has become one of the latest movements in the scientific field.

"The Holy Grail right now is the pre-symptomatic diagnosis and treatment of Parkinson's," Buck professor Julie Andersen told the crowd. "The key thing is, 'Can we treat you before you actually show symptoms of the disease?'"

Andersen and Alison McCormack of the Parkinson's Institute in Sunnyvale described in detail the latest research by their organizations in the seminar, titled "Parkinson's Disease: From Bench to Bedside." The key, they said, is turning the latest research into clinical diagnosis and treatment for patients before they show prevalent symptoms such as hand tremors, rigidity and postural instability.

Andersen said there are no standard tests available to make a diagnosis in people before they show symptoms, but advances are being made. Much of the effort in that regard is focusing on bringing down costs for imaging tests such as MRIs that could help with early detection.

McCormack said her institute's research has shown a high prevalence for impaired sense of smell among those who eventually get Parkinson's but who have yet to display other signs of the disease.

Both professors said that aging and environmental factors such as exposure to pesticides remain the primary causes. There are more than 1.5 million people worldwide suffering from Parkinson's at a cost of $6 billion annually. The rate of contracting it jumps from 1 out of 100 for people over age 65 to 1 out of 30 for those over age 85.

Many attendees said they had Parkinson's and were hoping to learn more both about the causes and new treatments.
Judith Geri, 64, of Petaluma said that people who don't yet have Parkinson's are less likely to attend a seminar on the disease. "But most of the research we heard about today is for people that don't have Parkinson's yet," she said. "All of the new tests are for people who just started showing symptoms. What are they going to do for the people who already have it?"

Recent News

May 2 - What's Good For The Heart Is Good For The Brain
Apr 29 - Press Release: FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease
Apr 28 - Dopamine-making neurons can be chemically controlled in animal model of Parkinson's
Apr 25 - Lifestyle: Dating with Disease
Apr 25 - Scientific breakthrough in fight against Parkinson's and Alzheimer's
Apr 20 - Breakthrough Parkinson's disease blood test
Apr 12 - Tissue biomarker for dementia with Lewy bodies and Parkinson’s disease
Apr 11 - Yoga for Every Body: Experts say yoga can ease pain and improve mobility for people with neurologic conditions
Apr 9 - Commonly prescribed Parkinson's drugs up risk of compulsive gambling, shopping, binge eating, hypersexuality
Apr 7 - Pfizer and IBM Launch Innovative Research Project to Transform Parkinson's Disease Care
Apr 7 - Parkinson's Drug Highly Effective for Resistant Depression
Apr 5 - Speech therapy program helps Parkinson’s patients regain speaking ability
Apr 4 - New research maps out pesticide exposure and Parkinson's disease in Nebraska
Apr 4 - The rogue immune cells that wreck the brain
Mar 28 - Chemists identify structure of protein that forms fibrils in Parkinson's patients
Mar 25 - UPDATE 1-FDA staff says Acadia's drug for Parkinson's disease psychosis is effective
Mar 23 - The virus that could cure Alzheimer's, Parkinson's and more
Mar 21 - Antipsychotic drugs may do significantly more harm to Parkinson's disease patients
Mar 21 - Rosacea Might Boost Parkinson's Risk: Study
Mar 21 - Apple CareKit Could Completely Change What It's Like To Live With Parkinson's Disease & Epilepsy